Midazolam
Revision Date : 16-11-2020
|
Approved: TC, KOH
|
Alert
High risk medication causing significant patient harm when used in error.
Indication
Sedation during ventilation or procedure.
Treatment of refractory seizure.
Action
Intensify the physiological inhibitory mechanisms mediated by gamma-aminobutyric acid (GABA) by accumulation and occupation of benzodiazepine receptors. Anti-anxiety properties are related to increasing the glycine inhibitory neurotransmitter.
Drug type
Short acting benzodiazepine.
Trade name
Hypnovel, Midazolam Alphapharm,, Midazolam Pfizer,, Midazolam-Baxter, B.Braun Midazolam, Midazolam Accord, Midazolam Apotex.
Presentation
5 mg/mL, 5mg/5mL, 150mg/10mL and 15mg/3mL ampoules used for IV and oral use
Dose
| 